HIV and Malignancy Scientific Working Group

Harvard University, Cambridge MA

Investigators

Linked publications, trials & patents

Abstract

PROJECT SUMMARY/ABSTRACT: HIV and Malignancy Scientific Working Group The overall goal of the HU CFAR HIV & Malignancy Scientific Working Group (SWG) is to address this growing burden of malignancies among PLWH by 1) engaging community partners, clinicians, and scientists; 2) facilitating clinical and specimen data synthesis and interpretation; and 3) supporting investigators, especially Early Career Investigators (ECIs). Through these activities, we will accelerate the discovery of mechanisms and interventions to prevent and treat cancers among PLWH. A key theme through these three aims is catalyzing translational research and identifying priorities at each translational stage and guide the process to ultimately have impact on individual and population-level health. The HU CFAR is uniquely positioned to leverage experts, clinical and basic science resources, and data and specimens to address scientific questions about HIV and malignancies. To continue to provide high-impact, rigorous training and mentorship for ECIs, we propose the following Specific Aims: 1) Support high-priority, cross-disciplinary HIV research activities at Harvard University and with international colleagues through Developmental and Mentoring Core Scholar Awards. 2) Foster leadership development at Harvard and affiliated international sites through a mentoring program for ECIs and structured training opportunities for their mentors.3) Grow and diversify the HU CFAR community through formal outreach and orientation activities, linkage with Scientific Working Groups, and funding opportunities that support diversity, equity, and inclusion.